These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22937108)

  • 41. Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease.
    Zeisberg M; Khurana M; Rao VH; Cosgrove D; Rougier JP; Werner MC; Shield CF; Werb Z; Kalluri R
    PLoS Med; 2006 Apr; 3(4):e100. PubMed ID: 16509766
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metformin ameliorates the severity of experimental Alport syndrome.
    Omachi K; Kaseda S; Yokota T; Kamura M; Teramoto K; Kuwazuru J; Kojima H; Nohara H; Koyama K; Ohtsuki S; Misumi S; Takeo T; Nakagata N; Li JD; Shuto T; Suico MA; Miner JH; Kai H
    Sci Rep; 2021 Mar; 11(1):7053. PubMed ID: 33782421
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Notoginsenoside R1 ameliorates podocyte injury in rats with diabetic nephropathy by activating the PI3K/Akt signaling pathway.
    Huang G; Lv J; Li T; Huai G; Li X; Xiang S; Wang L; Qin Z; Pang J; Zou B; Wang Y
    Int J Mol Med; 2016 Oct; 38(4):1179-89. PubMed ID: 27571993
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Neutralizing IL-11 Antibody Improves Renal Function and Increases Lifespan in a Mouse Model of Alport Syndrome.
    Widjaja AA; Shekeran SG; Adami E; Ting JGW; Tan J; Viswanathan S; Lim SY; Tan PH; Hübner N; Coffman T; Cook SA
    J Am Soc Nephrol; 2022 Apr; 33(4):718-730. PubMed ID: 35140116
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome.
    Tanaka M; Asada M; Higashi AY; Nakamura J; Oguchi A; Tomita M; Yamada S; Asada N; Takase M; Okuda T; Kawachi H; Economides AN; Robertson E; Takahashi S; Sakurai T; Goldschmeding R; Muso E; Fukatsu A; Kita T; Yanagita M
    J Clin Invest; 2010 Mar; 120(3):768-77. PubMed ID: 20197625
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discoidin domain receptor 1 activation links extracellular matrix to podocyte lipotoxicity in Alport syndrome.
    Kim JJ; David JM; Wilbon SS; Santos JV; Patel DM; Ahmad A; Mitrofanova A; Liu X; Mallela SK; Ducasa GM; Ge M; Sloan AJ; Al-Ali H; Boulina M; Mendez AJ; Contreras GN; Prunotto M; Sohail A; Fridman R; Miner JH; Merscher S; Fornoni A
    EBioMedicine; 2021 Jan; 63():103162. PubMed ID: 33340991
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Collagen receptors integrin alpha2beta1 and discoidin domain receptor 1 regulate maturation of the glomerular basement membrane and loss of integrin alpha2beta1 delays kidney fibrosis in COL4A3 knockout mice.
    Rubel D; Frese J; Martin M; Leibnitz A; Girgert R; Miosge N; Eckes B; Müller GA; Gross O
    Matrix Biol; 2014 Feb; 34():13-21. PubMed ID: 24480069
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Alport syndrome: Hereditary nephropathy associated with mutations in genes coding for type IV collagen chains].
    Heidet L; Gubler MC
    Nephrol Ther; 2016 Dec; 12(7):544-551. PubMed ID: 27816395
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Integrin alpha1beta1 regulates matrix metalloproteinases via P38 mitogen-activated protein kinase in mesangial cells: implications for Alport syndrome.
    Cosgrove D; Meehan DT; Delimont D; Pozzi A; Chen X; Rodgers KD; Tempero RM; Zallocchi M; Rao VH
    Am J Pathol; 2008 Mar; 172(3):761-73. PubMed ID: 18258846
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cyclosporine a slows the progressive renal disease of alport syndrome (X-linked hereditary nephritis): results from a canine model.
    Chen D; Jefferson B; Harvey SJ; Zheng K; Gartley CJ; Jacobs RM; Thorner PS
    J Am Soc Nephrol; 2003 Mar; 14(3):690-8. PubMed ID: 12595505
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transcriptional suppression of nephrin in podocytes by macrophages: roles of inflammatory cytokines and involvement of the PI3K/Akt pathway.
    Takano Y; Yamauchi K; Hayakawa K; Hiramatsu N; Kasai A; Okamura M; Yokouchi M; Shitamura A; Yao J; Kitamura M
    FEBS Lett; 2007 Feb; 581(3):421-6. PubMed ID: 17239861
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The renal lesions of Alport syndrome.
    Heidet L; Gubler MC
    J Am Soc Nephrol; 2009 Jun; 20(6):1210-5. PubMed ID: 19470679
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular and functional characterization of urine-derived podocytes from patients with Alport syndrome.
    Iampietro C; Bellucci L; Arcolino FO; Arigoni M; Alessandri L; Gomez Y; Papadimitriou E; Calogero RA; Cocchi E; Van Den Heuvel L; Levtchenko E; Bussolati B
    J Pathol; 2020 Sep; 252(1):88-100. PubMed ID: 32652570
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathological features of proteinuric nephropathy resembling Alport syndrome in a young Pyrenean Mountain dog.
    Sugahara G; Naito I; Miyagawa Y; Komiyama T; Takemura N; Kobayashi R; Mineshige T; Kamiie J; Shirota K
    J Vet Med Sci; 2015 Sep; 77(9):1175-8. PubMed ID: 25892536
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rho-kinase inhibition prevents proteinuria in immune-complex-mediated antipodocyte nephritis.
    Meyer-Schwesinger C; Dehde S; Sachs M; Mathey S; Arefi K; Gatzemeier S; Balabanov S; Becker JU; Thaiss F; Meyer TN
    Am J Physiol Renal Physiol; 2012 Oct; 303(7):F1015-25. PubMed ID: 22811486
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A COL4A3 gene mutation and post-transplant anti-alpha 3(IV) collagen alloantibodies in Alport syndrome.
    Kalluri R; van den Heuvel LP; Smeets HJ; Schroder CH; Lemmink HH; Boutaud A; Neilson EG; Hudson BG
    Kidney Int; 1995 Apr; 47(4):1199-204. PubMed ID: 7783419
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intrinsic proinflammatory signaling in podocytes contributes to podocyte damage and prolonged proteinuria.
    Brähler S; Ising C; Hagmann H; Rasmus M; Hoehne M; Kurschat C; Kisner T; Goebel H; Shankland S; Addicks K; Thaiss F; Schermer B; Pasparakis M; Benzing T; Brinkkoetter PT
    Am J Physiol Renal Physiol; 2012 Nov; 303(10):F1473-85. PubMed ID: 22975019
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alport syndrome. An inherited disorder of renal, ocular, and cochlear basement membranes.
    Kashtan CE
    Medicine (Baltimore); 1999 Sep; 78(5):338-60. PubMed ID: 10499074
    [TBL] [Abstract][Full Text] [Related]  

  • 59. X-Linked Alport Dogs Demonstrate Mesangial Filopodial Invasion of the Capillary Tuft as an Early Event in Glomerular Damage.
    Clark SD; Nabity MB; Cianciolo RE; Dufek B; Cosgrove D
    PLoS One; 2016; 11(12):e0168343. PubMed ID: 27959966
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neutrophil gelatinase-associated lipocalin is instrumental in the pathogenesis of antibody-mediated nephritis in mice.
    Pawar RD; Pitashny M; Gindea S; Tieng AT; Levine B; Goilav B; Campbell SR; Xia Y; Qing X; Thomas DB; Herlitz L; Berger T; Mak TW; Putterman C
    Arthritis Rheum; 2012 May; 64(5):1620-31. PubMed ID: 22083497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.